DLB vs RGLD
Dolby Laboratories, Inc. and Royal Gold Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DLB | RGLD |
|---|---|---|
| Revenue | $1.3B | $1.0B |
| Net income | $255.0M | $466.3M |
| Gross margin | 88.1% | 69.3% |
| Net margin | 19.0% | 45.8% |
| Return on equity | 10.0% | 9.1% |
| Diluted EPS | $2.62 | $6.69 |
| Dividend / share | $1.32 | $1.82 |
| Payout ratio | 49.6% | 25.4% |
| Free cash flow | $435.9M | · |
| Equity | $2.6B | $7.2B |
| Net debt / equity | · | 0.09× |
| Current ratio | 3.17× | 3.12× |
| Revenue CAGR 5y | 3.0% | 10.8% |
| Profit CAGR 5y | 2.0% | 9.0% |
DLB bills 1.3× the revenue of RGLD, and RGLD keeps more of each dollar of revenue as profit (45.8% against 19.0%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | DLB | RGLD |
|---|---|---|
| FY2025 | $1.3B | $1.0B |
| FY2024 | $1.3B | $719.4M |
| FY2023 | $1.3B | $605.7M |
| FY2022 | $1.3B | $603.2M |
| FY2021 | $1.3B | $653.6M |
| FY2020 | $1.2B | $615.9M |
| FY2019 | $1.2B | $498.8M |
| FY2018 | $1.1B | $423.1M |
| FY2017 | $1.1B | $459.0M |
| FY2016 | $1.0B | $440.8M |
Bottom line
| Fiscal year | DLB | RGLD |
|---|---|---|
| FY2025 | $255.0M | $466.3M |
| FY2024 | $261.8M | $332.0M |
| FY2023 | $200.7M | $239.4M |
| FY2022 | $184.1M | $239.0M |
| FY2021 | $310.2M | $274.0M |
| FY2020 | $231.4M | $302.5M |
| FY2019 | $255.2M | $199.3M |
| FY2018 | $41.7M | $93.8M |
| FY2017 | $206.5M | $-113.1M |
| FY2016 | $185.9M | $101.5M |
13 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$318,659,000 | DLB |
| FY2024 | +$554,326,000 | DLB |
| FY2023 | +$694,027,000 | DLB |
| FY2022 | +$650,587,000 | DLB |
| FY2021 | +$627,688,000 | DLB |
| FY2020 | +$545,936,000 | DLB |
| FY2019 | +$742,801,000 | DLB |
| FY2018 | +$631,544,000 | DLB |
| FY2017 | +$621,135,000 | DLB |
| FY2016 | +$584,924,000 | DLB |
| FY2015 | +$681,827,000 | DLB |
| FY2014 | +$715,607,000 | DLB |
| FY2013 | +$681,670,000 | DLB |
DLB has reported the higher revenue in every one of these 13 fiscal years. The gap has narrowed since the earliest year compared.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
13 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −26.8 pp | RGLD |
| FY2024 | −25.5 pp | RGLD |
| FY2023 | −24.1 pp | RGLD |
| FY2022 | −25.1 pp | RGLD |
| FY2021 | −17.3 pp | RGLD |
| FY2020 | −29.2 pp | RGLD |
| FY2019 | −18.8 pp | RGLD |
| FY2018 | −17.0 pp | RGLD |
| FY2017 | +45.2 pp | DLB |
| FY2016 | −2.8 pp | RGLD |
| FY2015 | +47.4 pp | DLB |
| FY2014 | +0.2 pp | DLB |
| FY2013 | −6.9 pp | RGLD |
The higher net margin has changed hands between DLB and RGLD over this period.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
RGLD's net margin has been more volatile than DLB's over the 13 comparable fiscal years — 24.7 percentage points of standard deviation against 4.8.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between DLB and RGLD over these 13 fiscal years — DLB led in 3 and RGLD in 10.
13 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DLB's return on equity has been more volatile than RGLD's over the 18 comparable fiscal years — 4.7 percentage points of standard deviation against 4.6.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between DLB and RGLD over these 18 fiscal years — DLB led in 14 and RGLD in 4.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.